US Patent Issued to CROSSJECT on Oct. 27 for "Pharmaceutical hydrocortisone solution for injection device" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,413, issued on Oct. 27, was assigned to CROSSJECT (Dijon, France).

"Pharmaceutical hydrocortisone solution for injection device" was invented by Laurette Vincent (Dijon, France), Olivier Lacombe (Talant, France) and Marion Iguiniz (Quetigny, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical solution of hydrocortisone includes in mg per 1 mL of solution: between 150 mg and 170 mg of hydrocortisone or a pharmaceutically acceptable salt thereof in equivalent amount, between 2 mg and 7.5 mg of monothioglycerol, and Qsp 1 mL of solvent. The solution is used in the treatment of acute adrenal insufficiency and asthma and concerns an in...